500 Fifth St, NW
Washington, DC 20001
The latest news from HMD, including information about new reports, activities, meetings, and other noteworthy events.
Displaying: 1 to 1 of 1 News and Announcements
On June 30, 2008, the Food and Drug Administration (FDA) shifted authority on drug safety regulatory issues from the Office of New Drugs (OND) to a shared responsibility between OND and the Office of Surveillance and Epidemiology (OSE) as recommended in the IOM report The Future of Drug Safety: Promoting and Protecting the Health of the Public.